These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1107431)

  • 1. Reproducibility of the immunofluorescent test for antimelanoma antibodies.
    Abel EA; Bystryn JC
    J Invest Dermatol; 1976 Feb; 66(02):117-21. PubMed ID: 1107431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies in malignant melanoma patients.
    Betterle C; Peserico A; Bersani G; Ninfo V; Del Prete GF; Stefani R; Nitti D
    Dermatologica; 1979; 159(1):24-9. PubMed ID: 383530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescent studies of the serologic reactivity of patients with malignant melanoma against tumor-associated cytoplasmic antigens.
    Wood GW; Barth RF
    J Natl Cancer Inst; 1974 Aug; 53(2):309-16. PubMed ID: 4602060
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.
    Abel EA; Bystryn JC
    J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of antimelanoma monoclonal antibodies, with special reference to fetal tissue distribution.
    Kageshita T; Johno M; Ono T; Arao T; Imai K
    J Invest Dermatol; 1985 Dec; 85(6):535-7. PubMed ID: 3905976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different fixatives on the localization of human melanoma antigens by immunofluorescence.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Oncology; 1979; 36(5):202-7. PubMed ID: 384307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent antibody studies in malignant melanoma.
    Whitehead RH
    Br J Cancer; 1973 Dec; 28(6):525-9. PubMed ID: 4205845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
    Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
    Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cytoplasmic humoral antibody test. A diagnostic adjunct.
    Copeman PW; Elliott PG
    Br J Dermatol; 1976 May; 94(5):565-8. PubMed ID: 773408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The properties of antibody against smooth endoplasmic reticulum of melanocytes.
    Kato T; Seiji M
    Tohoku J Exp Med; 1980 Apr; 130(4):311-20. PubMed ID: 6781102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescent detection of antibodies to ocular melanomas.
    Wong IG; Oskvig RM
    Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
    Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimelanoma antibodies in swine with spontaneously regressing melanoma.
    Cui J; Chen D; Misfeldt ML; Swinfard RW; Bystryn JC
    Pigment Cell Res; 1995 Feb; 8(1):60-3. PubMed ID: 7792256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens and antibodies in malignant melanoma.
    Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P
    Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies in patients with malignant melanoma of the uvea.
    Brownstein S; Sheikh KM; Lewis MG
    Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human malignant melanoma antigens by immunofluorescence and autologous postimmune antimelanoma sera.
    Leong SP
    Ann N Y Acad Sci; 1983; 420():237-50. PubMed ID: 6372592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
    Seibert E; Sorg C; Happle R; Macher E
    Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines.
    Dent PB; Liao SK; McCulloch PB; Stone BR; Singal DP
    Cancer; 1982 May; 49(10):2043-8. PubMed ID: 6176308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.